Pharmacyclics LLC v. BeOne Medicines USA, Inc.
1:23-cv-00646
Overview
Parties
Defendant
BeOne Medicines Ltd. Operating Company
Represented By
4 Attorneys ListedWilliams & Connolly LLP - Washington
725 Twelfth St, NW, Washington, DC 20005
Wilks Law, LLC
4250 Lancaster Pike, Suite 200
Wilks Law, LLC
4250 Lancaster Pike, Suite 200
BeOne Medicines USA, Inc. Operating Company
Represented By
4 Attorneys ListedWilliams & Connolly LLP - Washington
725 Twelfth St, NW, Washington, DC 20005
Wilks Law, LLC
4250 Lancaster Pike, Suite 200
Wilks Law, LLC
4250 Lancaster Pike, Suite 200
BeiGene, Ltd. Operating Company
Represented By
7 Attorneys ListedWilliams & Connolly LLP - Washington
725 Twelfth St, NW, Washington, DC 20005
Wilks Law, LLC
4250 Lancaster Pike, Suite 200
Wilks Law, LLC
4250 Lancaster Pike, Suite 200
BeiGene USA, Inc. Operating Company
Represented By
7 Attorneys ListedWilliams & Connolly LLP - Washington
725 Twelfth St, NW, Washington, DC 20005
Wilks Law, LLC
4250 Lancaster Pike, Suite 200
Wilks Law, LLC
4250 Lancaster Pike, Suite 200
Plaintiff
Pharmacyclics LLC Operating Company
Represented By
2 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360° Radar 19 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| 🇺🇸 United States | Asserted | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → |
No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.
Patents Involved
There is a single patent involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US11672803
Use of inhibitors of Brutons tyrosine kinase (Btk)
|
Filed: 2020-07-10
Issued: 2023-06-13
|
Active (13.6 yrs remaining)
Expires: 2040-07-10
|
Patent Enforceability & Injunction Risk Assessment
Active Threat — Patent is within enforceable statutory term; injunctive relief viable.
Standard Statutory Term — No obviousness-type double patenting noted.
Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. Standard Maintenance Fee Schedule Tracked.
Procedural Motions & Interlocutory Orders
Total Motions
10
Dispositive
0
Granted
4
Denied
0
Pending / Review
3
Motions by Category
Key Dispositive Motions & Rulings